Navigation Links
Orthofeet Expands Sales and Operations Management
Date:11/14/2011

NORTHVALE, N.J., Nov. 14, 2011 /PRNewswire/ -- Orthofeet, a leading manufacturer of premium quality therapeutic footwear, today announced a new sales and operations management team, comprised of hires and internal promotions.  The seasoned team represents the first internal changes since the new executive leadership was established last July.

Joining Orthofeet will be Charles Liberge as Vice President, Business Development and Cyndee Fitzsimmons, Director of Sales.  Additionally, Mike Saccente is promoted to Director, NJ Operations and Paul Barattiero, C. Ped., is appointed to VP, Sales Training and Development.

"We are confident that we've put into place the right mix of executives and a highly effective structure to help achieve our growth aspirations," said Mark Koide, CEO, Orthofeet.  "This collective group combines long term Orthofeet operational expertise with professionals who have consistently demonstrated their ability to grow businesses and build brands."

Well regarded as a footwear industry leader, Charles Liberge comes to Orthofeet with extensive experience in all aspects of developing and managing growth oriented organizations, including success at Stride Rite, Earth Brand Footwear, KangaROOS and Klas Shoes.  In his new role, Mr. Liberge will oversee strategy and execution over a number of business initiatives that have high growth potential and require highly focused resources.

Cyndee Fitzsimmons joins the company from P.W. Minor where she was Director, Sales.  Her responsibilities will include the development and management of corporate sales plans, including inside sales management and forecasting.

Mike Saccente is a 20-year Orthofeet veteran, having worked in multiple Operations positions within the company.  Mr. Saccente will continue to oversee customer service and will now be responsible for warehousing and transportation.

Paul Barattiero has been with Orthofeet for 4 years and will now be responsible for training and development of the company's staff and representatives, external education programs, research and tradeshows.

Orthofeet is the premium brand of specialty footwear biomechanically designed to provide consumers with ultimate mobility, comfort and protection for an improved quality of life.  The company was established in 1985 by the Bar brothers, two biomedical engineers who pioneered innovations in footwear construction unmatched in the industry.  In order to maintain its high level of quality and service, Orthofeet produces most of its products through company owned plants. Orthofeet partners with medical professionals and DME providers throughout the US to provide patients with a great selection of therapeutic shoes, insoles and socks. For more information visit www.orthofeet.com.


'/>"/>
SOURCE Orthofeet
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Expands Infant Formula Distribution in China With Brilite Nutritionals (Shanghai) Co., Ltd.
2. Regulus Therapeutics Expands Worldwide Patent Coverage on microRNA-122 to Treat Hepatitis C Virus (HCV) Infection
3. Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex® System
4. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
5. CPhI Global Portfolio Expands into South East Asia
6. Awarepoint Expands Senior Management Team
7. Perrigo Expands Infant Formula Distribution in China With Founder Group
8. GTX Corp Expands Partner Alliance in Preparation for GPS Shoe Launch
9. GNS Healthcare, Inc. Expands Senior Management Team to Leverage the Rapidly Growing Opportunities for Big Data in Healthcare Management
10. Fujifilm Expands FDR D-EVO™ Wireless Product Line With New 17x17 Inch Detector
11. Inogens Home Oxygen Therapy Service Expands to Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... , Mar 01, 2017 Research and ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... 2016, provides drug pricing data and benchmarks in the global Acute ... clinical attributes of your competitor drugs and find out how the ...
(Date:3/1/2017)... -- The global  Intraoperative Neuromonitoring (IONM) market  is expected to reach ... Research, Inc. The intraoperative neuromonitoring market is anticipated to witness significant growth in ... in a wide spectrum of surgeries. Continue Reading ... ... ...
(Date:3/1/2017)... El mismo sistema se mostrará en el Congreso Europeo de Radiología (CER) en Viena. ... ... open MRI scanner - MROpen engineered and developed by Paramed in the ESC Cardiff ... Paramed Medical Systems ... Gales. El escáner se localizará en el nuevo centro del European Scanning Centre situado en ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... March 01, 2017 , ... After a long period of indulging ... While juice cleanses and workouts top the detox categories, there is a rare yet ... The Kerry Gaynor Method’s Vital Lung Detox is an herbal-based formula designed to help ...
(Date:3/1/2017)... ... 01, 2017 , ... Look for a new collection of edible berry plants ... Star Roses and Plants is launching their new Bushel and Berry Collection , ... Collection makes growing fresh fruit simple with a variety of easy-to-grow, low-maintenance container berry ...
(Date:3/1/2017)... CA (PRWEB) , ... March 01, 2017 , ... Breast ... for the treatment of early stage breast cancer and where it fits in the ... & The Choices We Make .” The event brings together leading cancer and wellness ...
(Date:3/1/2017)... ... March 01, 2017 , ... Granite Peaks ... cancer screening rates by supporting the 80% by 2018 initiative, led by the ... the National Colorectal Cancer Roundtable (an organization co-founded by ACS and CDC). , ...
(Date:3/1/2017)... ... 2017 , ... “There is Comfort for the Soul”: a loving account of ... all-too-brief time together, and the soul-healing comfort provided by God’s presence in the face ... author, Jerie A. Tau, a dog-loving medical professional whose work takes her to remote ...
Breaking Medicine News(10 mins):